全文获取类型
收费全文 | 10024篇 |
免费 | 533篇 |
国内免费 | 93篇 |
专业分类
耳鼻咽喉 | 113篇 |
儿科学 | 209篇 |
妇产科学 | 89篇 |
基础医学 | 1141篇 |
口腔科学 | 175篇 |
临床医学 | 745篇 |
内科学 | 3061篇 |
皮肤病学 | 73篇 |
神经病学 | 628篇 |
特种医学 | 509篇 |
外科学 | 1690篇 |
综合类 | 45篇 |
预防医学 | 270篇 |
眼科学 | 101篇 |
药学 | 444篇 |
中国医学 | 8篇 |
肿瘤学 | 1349篇 |
出版年
2023年 | 154篇 |
2022年 | 284篇 |
2021年 | 454篇 |
2020年 | 224篇 |
2019年 | 281篇 |
2018年 | 370篇 |
2017年 | 253篇 |
2016年 | 273篇 |
2015年 | 254篇 |
2014年 | 368篇 |
2013年 | 398篇 |
2012年 | 690篇 |
2011年 | 720篇 |
2010年 | 415篇 |
2009年 | 327篇 |
2008年 | 567篇 |
2007年 | 545篇 |
2006年 | 531篇 |
2005年 | 510篇 |
2004年 | 489篇 |
2003年 | 483篇 |
2002年 | 441篇 |
2001年 | 136篇 |
2000年 | 123篇 |
1999年 | 138篇 |
1998年 | 123篇 |
1997年 | 99篇 |
1996年 | 92篇 |
1995年 | 58篇 |
1994年 | 60篇 |
1993年 | 52篇 |
1992年 | 80篇 |
1991年 | 87篇 |
1990年 | 67篇 |
1989年 | 47篇 |
1988年 | 43篇 |
1987年 | 51篇 |
1986年 | 32篇 |
1985年 | 34篇 |
1984年 | 33篇 |
1983年 | 20篇 |
1982年 | 14篇 |
1981年 | 22篇 |
1980年 | 16篇 |
1979年 | 23篇 |
1978年 | 18篇 |
1977年 | 13篇 |
1974年 | 13篇 |
1973年 | 18篇 |
1968年 | 14篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Shitara K Ura T Matsuo K Takahari D Yokota T Yuki S Yoshida M Utsunomiya S Sato Y Yamaura H Kato M Inaba Y Tajika M Kawai H Yamazaki K Komatsu Y Muro K 《European journal of cancer (Oxford, England : 1990)》2011,47(18):2673-2680
The aim of this study was to evaluate the association of sensitivity to previous irinotecan-based chemotherapy with efficacy of cetuximab plus irinotecan therapy in metastatic colorectal cancer (MCRC) patients with wild-type KRAS. We analysed a pooled data set consisting of data from 87 MCRC patients from two previous phase II studies (n = 60) and a group given off-protocol treatment (n = 27) following irinotecan-, oxaliplatin-, and fluoropyrimidine-based chemotherapy. Overall objective response rate to cetuximab plus irinotecan was 28.7%, median progression-free survival (PFS) was 5.3 months, and median overall survival was 12.2 months. Objective response rate did not significantly differ between patients with a favourable response to previous irinotecan (n = 23), stable disease (n = 38), or progressive disease (n = 26), with observed rates of 29.2%, 31.6%, and 23.1%, respectively. Additionally, the non-parametric Spearman rank correlation coefficients (ρ) between the PFS of previous irinotecan-based chemotherapy and that of cetuximab plus irinotecan were quite low (ρ = 0.067 and 0.057 in patients with previous irinotecan as first- and second-line therapies, respectively). Although exploratory nature and small sample size may be limitations of this study, these findings indicate that the efficacy of irinotecan plus cetuximab in MCRC patients with wild-type KRAS did not differ by previous sensitivity to irinotecan. 相似文献
992.
Hara K Yamao K Mizuno N Hijioka S Sawaki A Tajika M Kawai H Kondo S Shimizu Y Niwa Y 《World journal of clinical oncology》2011,2(2):108-114
Endoscopic ultrasonography (EUS) represents the combination of endoscopy and intraluminal ultrasonography. This allows use of a high-frequency transducer (5-20 MHz) that, due to the short distance to the target lesion, provides ultrasonographic images of higher resolution than those obtained from other imaging modalities, including multiple-detector-row-computed tomography, magnetic resonance imaging, and positron emission tomography. EUS is now a widely accepted modality for diagnosing pancreatic diseases. However, the most important limitation of EUS has been the lack of specificity in differentiating between benign and malignant changes. In 1992, EUS-guided fine needle aspiration (FNA) of lesions in the pancreas head was introduced into clinical practice, using a curved linear-array echoendoscope. Since then, EUS has evolved from EUS imaging to EUS-FNA and wider applications. Interventional EUS for pancreatic cancer includes EUS-FNA, EUS-guided fine needle injection, EUS-guided biliary drainage and anastomosis, EUS-guided celiac neurolysis, radiofrequency ablation, brachytherapy, and delivery of a growing number of anti-tumor agents. This review focuses on interventional EUS, including EUS-FNA and therapeutic EUS for pancreatic cancer. 相似文献
993.
Takanari H Honjo H Takemoto Y Suzuki T Kato S Harada M Okuno Y Ashihara T Opthof T Sakuma I Kamiya K Kodama I 《Journal of pharmacological sciences》2011,115(1):15-26
Bepridil is effective for conversion of atrial fibrillation to sinus rhythm and in the treatment of drug-refractory ventricular tachyarrhythmias. We investigated the effects of bepridil on electrophysiological properties and spiral-wave (SW) reentry in a 2-dimensional ventricular muscle layer of isolated rabbit hearts by optical mapping. Ventricular tachycardia (VT) induced in the presence of bepridil (1 μM) terminated earlier than in the control. Bepridil increased action potential duration (APD) by 5% – 8% under constant pacing and significantly increased the space constant. There was a linear relationship between the wavefront curvature (κ) and local conduction velocity: LCV = LCV0 ? D·κ (D, diffusion coefficient; LCV0, LCV at κ = 0). Bepridil significantly increased D and LCV0. The regression lines with and without bepridil crossed at κ = 20 – 40 cm?1, resulting in a paradoxical decrease of LCV at κ > 40 cm?1. Dye transfer assay in cultured rat cardiomyocytes confirmed that bepridil increased intercellular coupling. SW reentry in the presence of bepridil was characterized by decremental conduction near the rotation center, prominent drift, and self-termination by collision with boundaries. These results indicate that bepridil causes an increase of intercellular coupling and a moderate APD prolongation, and this combination compromises wavefront propagation near the rotation center of SW reentry, leading to its drift and early termination.[Supplementary Figures: available only at http://dx.doi.org/10.1254/jphs.10233FP] 相似文献
994.
995.
Kohei Shitara Keitaro Matsuo Ayako Mizota Chihiro Kondo Motoo Nomura Daisuke Takahari Tomoya Yokota Takashi Ura Seiji Ito Akira Sawaki Masahiro Tajika Hiroki Kawai Kei Muro 《Gastric cancer》2011,14(2):155-160
Background
Although fluoropyrimidines, platinum agents, taxanes, and irinotecan are used in the treatment of advanced gastric cancer (AGC), it remains unclear whether these agents in any line of chemotherapy are associated with overall survival (OS) in these patients.Methods
We retrospectively analyzed 704 patients with AGC. To avoid possible lead-time bias, we applied time-varying covariate analysis for chemotherapy with four agents in any line.Results
Median OS was 12.3?months. The frequency of exposure to each agent class during all lines of treatment was 92.6% for FU (5-fluorouracil or oral fluoropyrimidine), 48.2% for platinum agents, 65.1% for taxanes, and 39.1% for irinotecan. According to a multivariate Cox model with exposure to each agent class as a time-varying covariate, the hazard ratios (HRs) of death were 0.41 (95% confidence interval [CI], 0.27??.57; p?<?0.001) for FU, 0.71 (95% CI, 0.58??.84; p?<?0.001) for platinum agents, 0.51 (95% CI, 0.41??.63; p?<?0.001) for taxanes, and 0.53 (95% CI, 0.43??.65; p?<?0.001) for irinotecan. Although other agents were used in 18.6% of the patients, they did not affect survival.Conclusions
Each of the four agent classes (FU, platinum agents, taxanes, and irinotecan) appears to be independently associated with improved OS in patients with AGC regardless of timing. This result suggests the importance of developing strategies which make these active agents available to all patients with AGC to prolong OS. 相似文献996.
997.
Marushima H Shibata S Asakura T Matsuura T Maehashi H Ishii Y Eda H Aoki K Iida Y Morikawa T Ohkawa K 《International journal of oncology》2011,39(5):1327-1336
In vitro tumor growth in a three-dimensional (3D) architecture has been demonstrated to play an important role in biology not only for developmental organogenesis and carcinogenesis, but also for analyses on reconstitution and maintenance in a variety of biological environments surrounding the cells. In addition to providing architectural similarity to living organisms, 3D culture with a radial flow bioreactor (RFB) can also closely mimic the living hypoxic microenvironment under which specific organogenesis or carcinogenesis occurs. The findings of the present study under the RFB culture conditions show that cancer cells underwent a shift from aerobic to hypoxic energy metabolism, in addition to protein expression to maintain the 3D structure. In RFB-cultured cells, protein stability of hypoxia-inducible factor 1 (HIF1) α, a subunit of HIF1, was increased without upregulation of its mRNA. Under these conditions, PHD2, HIF-prolyl-4-hydroxy-lase 2 and a HIF1 downstream enzyme, were stabilized without affecting the mRNA levels via downregulation of FK506-binding protein 8. PHD2 accumulation, which occurred concomitant with HIF1 stabilization, may have compensated for the lack of oxygen under hypoxic conditions to regulate the HIF levels. 3D-culture-induced overexpression of carbonic anhydrase (another representative HIF downstream enzyme) was found to occur independently of cell density in RFB--cultured cells, suggesting that the RFB provided an adequately hypoxic microenvironment for the cultured cells. From these results, it was hypothesized that the key factors are regulatory molecules, which stabilize and degrade HIF molecules, thereby activating the HIF1 pathway under a hypoxic milieu. 相似文献
998.
999.
Iwahashi S Shimada M Utsunomiya T Morine Y Imura S Ikemoto T Mori H Hanaoka J Sugimoto K Saito Y 《International journal of clinical oncology / Japan Society of Clinical Oncology》2011,16(6):671-678